Weight loss

Exenatide (Byetta) was approved by the Food and Drug Administration in April 2005 for the treatment of type 2 diabetes.

Although taken as a twice-daily injection, Byetta is not insulin.

Byetta improves blood sugar control by mimicking the action of the hormone incretin.

Among other things, Byetta allows insulin to work more effectively in the body.

Studies of Byetta found that it not only improved blood sugar control but also led to It is unclear exactly how Byetta causes As a result, people taking Byetta may feel "full" faster and longer, so they eat less.

The most common side effect with Byetta is mild to moderate nausea, which improves with time in most people.

Byetta is designed for people who have diabetes and has not been studied as a weight-loss aid in people with normal blood sugar.

If you have diabetes and wonder if Byetta may be helpful, talk to your doctor.

MORE ON THIS TOPIC Insulin therapy: Does it cause weight gain?

RELATED Articles Exubera: Inhaled insulin approved by FDA Type 1 diabetes Type 2 diabetes Ask a Specialist Type 1 diabetes: Is it inherited?

Centers Diabetes Center ARTICLE TOOLS Print Larger type more information By Mayo Clinic Staff Mar 30, 2006 © 1998-2006 Mayo Foundation for Medical Education and Research (MFMER).

All rights reserved.  A single copy of these materi...

Read more...